Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Exelixis Inc (NASDAQ:EXEL)

4.61
Delayed Data
As of Apr 29
 +0.07 / +1.54%
Today’s Change
2.51
Today|||52-Week Range
6.81
-18.26%
Year-to-Date

Today’s Trading

Previous close4.54
Today’s open4.51
Day’s range4.51 - 4.68
Volume3,532,650
Average volume (3 months)4,584,557
Market cap$1.0B
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)-14.81%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+48.03%
P/E ratioNM
Price/Sales31.75
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NXTMNxStage Medical Inc-0.47-2.83%
FGENFibroGen Inc-0.77-4.10%
ABCOAdvisory Board Co-0.09-0.28%
ARIAARIAD Pharmaceutical...+0.01+0.14%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$37.2M
Annual profit (last year)-$169.7M
Net profit margin-456.63%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer &
Executive Vice President
Christopher J. Senner
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs